283 related articles for article (PubMed ID: 21993569)
1. Prevalence of potential drug-drug interactions in bone marrow transplant patients.
Guastaldi RB; Reis AM; Figueras A; Secoli SR
Int J Clin Pharm; 2011 Dec; 33(6):1002-9. PubMed ID: 21993569
[TBL] [Abstract][Full Text] [Related]
2. Potential drug-drug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay.
Sanchez L; Bacle A; Lamy T; Le Corre P
Cancer Chemother Pharmacol; 2019 May; 83(5):827-835. PubMed ID: 30758649
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of potential drug-drug interactions in the elderly: a cross-sectional study in the brazilian primary public health system.
Obreli Neto PR; Nobili A; Marusic S; Pilger D; Guidoni CM; Baldoni Ade O; Cruciol-Souza JM; Da Cruz AN; Gaeti WP; Cuman RK
J Pharm Pharm Sci; 2012; 15(2):344-54. PubMed ID: 22579012
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
[TBL] [Abstract][Full Text] [Related]
5. Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
Fettah H; Moutaouakkil Y; Sefrioui MR; Moukafih B; Bousliman Y; Bennana A; Lamsaouri J; Makram S; Cherrah Y
Pan Afr Med J; 2018; 29():225. PubMed ID: 30100979
[TBL] [Abstract][Full Text] [Related]
6. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
Dechanont S; Maphanta S; Butthum B; Kongkaew C
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
[TBL] [Abstract][Full Text] [Related]
7. Real clinical impact of drug-drug interactions of immunosuppressants in transplant patients.
Gago-Sánchez AI; Font P; Cárdenas M; Aumente MD; Del Prado JR; Calleja MÁ
Pharmacol Res Perspect; 2021 Dec; 9(6):e00892. PubMed ID: 34755493
[TBL] [Abstract][Full Text] [Related]
8. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Significance of Potential Pharmacokinetic Drug-Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials.
Rashdan S; Yang H; Le T; Selby C; Gerber DE; Alvarez CA
Clin Drug Investig; 2021 Feb; 41(2):161-167. PubMed ID: 33417195
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of drug-drug interaction in atrial fibrillation patients based on a large claims data.
Momo K; Kobayashi H; Sugiura Y; Yasu T; Koinuma M; Kuroda SI
PLoS One; 2019; 14(12):e0225297. PubMed ID: 31815956
[TBL] [Abstract][Full Text] [Related]
11. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
Moura C; Prado N; Acurcio F
Clin Drug Investig; 2011; 31(5):309-16. PubMed ID: 21344954
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
13. Potential drug-drug interactions within Veterans Affairs medical centers.
Mahmood M; Malone DC; Skrepnek GH; Abarca J; Armstrong EP; Murphy JE; Grizzle AJ; Ko Y; Woosley RL
Am J Health Syst Pharm; 2007 Jul; 64(14):1500-5. PubMed ID: 17617500
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
Lin CF; Wang CY; Bai CH
Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.
Khan Q; Ismail M; Haider I; Khan F
Int J Clin Pharm; 2017 Dec; 39(6):1256-1264. PubMed ID: 28895028
[TBL] [Abstract][Full Text] [Related]
16. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
[TBL] [Abstract][Full Text] [Related]
17. Drug-drug interactions in Neonatal Intensive Care Units: how to overcome a challenge.
Rosen K; Wiesen MH; Oberthür A; Michels G; Roth B; Fietz C; Müller C
Minerva Pediatr (Torino); 2021 Apr; 73(2):188-197. PubMed ID: 31621271
[TBL] [Abstract][Full Text] [Related]
18. Frequency, severity, and factors associated with clinically significant drug-drug interactions among patients with cancer attending Mbarara Regional Referral Hospital Cancer Unit, Uganda.
Luzze B; Atwiine B; Lugobe HM; Yadesa TM
BMC Cancer; 2022 Dec; 22(1):1266. PubMed ID: 36471270
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis.
Dieu LW; Leuppi-Taegtmeyer AB; van den Anker J; Trachsel D; Gotta V
Swiss Med Wkly; 2019 Aug; 149():w20103. PubMed ID: 31422575
[TBL] [Abstract][Full Text] [Related]
20. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]